U.S. Attorney | U.S. Patent Attorney

U.S. Patent Interference

In the U.S. patent interference proceedings listed below, Dr. Ruppert worked with teams consisting of U.S. attorneys, technical experts, and attorneys from the U.S. Department of Justice, as appropriate.

• Mophie, Inc. v. Incase Designs Corp. Patent Interference Proceeding No. 105,946 (U.S. Patent and Trademark Office).
  • Patent Interference Proceedings: Handled Mophie, Inc.’s patent application(s) relating to battery packs for mobile devices as counsel for Mophie, Inc. and obtained decision that all claims and all issued patents of the opposing party were included in the interference proceeding.

• The J. David Gladstone Institutes v. Oregon Health And Science University. Patent Interference Proceeding No. 105,686 (U.S. Patent and Trademark Office).
  • Patent Interference Proceedings: Assisted the J. David Gladstone Institutes in obtaining a favorable settlement in patent litigation involving HIV-1 technology.

• University of California v. Alza Corporation. Patent Interference Proceeding No. 105,332 (U.S. Patent and Trademark Office).
  • Patent Interference Proceedings: Obtained a priority judgment for the University of California in a case involving targeted therapeutic use of liposomes.

• Luciw v. Chang. Patent Interference Proceeding No. 105,291 (U.S. Patent and Trademark Office).
  • Patent Interference Proceedings: Counsel for the National Institutes of Health in a patent interference proceeding against Novartis/Chiron related to first-generation HIV-1 hybridization assays. Obtained priority judgment for client.
  • Judgment affirmed on appeal.

• Chang v. Alizon. Patent Interference Proceeding No. 105,290 (U.S. Patent and Trademark Office).
  • Patent Interference Proceedings: Counsel for the National Institutes of Health in a patent interference proceeding against Institute Pasteur relating to a first-generation HIV-1 hybridization assays. Obtained priority judgment for client at conclusion of appeal in district court.